Offering an alternative to PMMA bone cement, a biological option for VCF repair has the potential to transform the way healthcare professionals approach repairing osteoporotic spinal fractures.
Read More
Articles by Lenoss Medical
Lenoss Medical, Inc. Selected for Prestigious MedTech Innovator 2026 Accelerator Cohort
MedTech Innovator (MTI) is the world’s largest accelerator for medical technology startups. The highly competitive four-month program provides participants with world-class mentorship, strategic guidance, and access to a robust network of investors, providers, payers, manufacturers, and industry experts.
Read More
Orthopedics This Week: Lenoss Medical Announces Successful Close of $6 Million Growth Bridge Financing
PROVIDENCE, RI, UNITED STATES, March 17, 2026 — Lenoss Medical, a biomedical growth stage company offering the first and only biological solution to the spinal vertebral augmentation market, today announced the successful closing of a $6 million growth bridge financing round, reinforcing strong investor confidence in the company’s commercial progress and […]
Read More
Lenoss Medical Announces Successful Close of $6 Million Growth Bridge Financing
News reinforces strong investor confidence in the company’s commercial progress and long-term growth strategy for its OsteoPearl® platform solution.
Read More
Lenoss Medical Expands OsteoPearl® Global Patent Protection, Transforming Future of Vertebral Compression Fracture Care
PROVIDENCE, RI, September 4, 2025 — Lenoss Medical, Inc., a pioneering medical device company focused on spinal fractures, today announced that it has received notice of allowance for two new US patents and the grant of one European patent, further extending the company’s patent protection of the OsteoPearl® Biological Allograft implant design and […]
Read More
Becker’s Spine: Lenoss Medical’s spine biologic hits 150 cases
More than half of the 150 cases were completed since September.
Read More
Accelerated by Series A, Lenoss Medical Hits Major Milestone in Commercialization of OsteoPearl Spinal Implant System
PROVIDENCE, RI, , March 27, 2025 — After successfully closing its $4 Million Series A financing, NEMIC fellow Lenoss Medical is celebrating the achievement of an important milestone–the completion of the 150th OsteoPearl procedure, more than half of which occurred in the last six months. The OsteoPearl implant is a novel biological allograft implant […]
Read More Lenoss Medical Oversubscribes $4 Million Series A Financing
The Series A was oversubscribed with participation from Xcellerant Ventures, Highpoint Ventures, Vodia Capital, RightHill Ventures, and various Angel Investment Groups.
Read More
Lenoss Medical to present cementless, physiological spinal fracture treatment solution at SIR 2022
Pioneering physiological treatment for osteoporotic vertebral compression fractures, Lenoss Medical is excited to announce its inaugural attendance at SIR 2022 – the Society of Interventional Radiology’s annual meeting in Boston – where it will showcase for the first time its OsteoPearl Cementless VBA System.
Read More
WJAR: There’s a new implant developed in Rhode Island to treat spine fractures
(WJAR) — There’s a new — first and only-one-of-its kind — implant to treat spine fractures. This idea was hatched in Rhode Island through a collaborative effort that encourages the creation of new medical technology. It’s called the New England Medical Innovation Center in Providence. It was there that a […]
Read More